33 results
-
List item
News: Hydroxyethyl-starch solutions for infusion recommended for suspension from the market (updated)
CMDh, Last updated: 25/05/2022 -
List item
Committee for Herbal Medicinal Products (HMPC): 28-30 March 2022 (updated)
from 28/03/2022 to 30/03/2022, Last updated: 19/05/2022 -
List item
Committee for Herbal Medicinal Products (HMPC): 20-22 September 2021
European Medicines Agency, Amsterdam, the Netherlands, from 20/09/2021 to 22/09/2021, Last updated: 07/12/2021 -
List item
Committee for Herbal Medicinal Products (HMPC): 22-24 November 2021
European Medicines Agency, Amsterdam, the Netherlands, from 22/11/2021 to 24/11/2021, Last updated: 07/12/2021 -
List item
Committee for Herbal Medicinal Products (HMPC): 18-20 November 2019
European Medicines Agency, Amsterdam, the Netherlands, from 18/11/2019 to 20/11/2019, Last updated: 19/11/2019 -
List item
Committee for Herbal Medicinal Products (HMPC): 14-16 January 2019
European Medicines Agency, London, UK, from 14/01/2019 to 16/01/2019, Last updated: 21/10/2019 -
List item
Committee for Herbal Medicinal Products (HMPC): 13-15 May 2019
European Medicines Agency, Amsterdam, the Netherlands, from 13/05/2019 to 15/05/2019, Last updated: 15/10/2019 -
List item
Committee for Herbal Medicinal Products (HMPC): 8-10 July 2019
European Medicines Agency, Amsterdam, the Netherlands, from 08/07/2019 to 10/07/2019, Last updated: 15/10/2019 -
List item
Committee for Herbal Medicinal Products (HMPC): 23-25 September 2019
European Medicines Agency, Amsterdam, the Netherlands, from 23/09/2019 to 25/09/2019, Last updated: 14/10/2019 -
List item
Press release: Hydroxyethyl starch solutions: CMDh introduces new measures to protect patients
CMDh, Last updated: 29/06/2018 -
List item
Press release: Withdrawal of pain medicine flupirtine endorsed
CMDh, Last updated: 23/03/2018 -
List item
Press release: New measures to avoid valproate exposure in pregnancy endorsed
CMDh, Last updated: 23/03/2018 -
List item
Press release: Hydroxyethyl-starch solutions for infusion to be suspended – CMDh endorses PRAC recommendation
CMDh, Last updated: 26/01/2018 -
List item
Press release: Modified-release paracetamol-containing products to be suspended from EU market
CMDh, Last updated: 15/12/2017 -
List item
Press release: CMDh endorses revocation of authorisations for fusafungine sprays used to treat airway infections
CMDh, Last updated: 01/04/2016 -
List item
Press release: Codeine not to be used in children below 12 years for cough and cold
CMDh, Last updated: 24/04/2015 -
List item
Press release: New restrictions to minimise the risks of effects on heart rhythm with hydroxyzine-containing medicines
CMDh, Last updated: 27/03/2015 -
List item
Press release: Ambroxol and bromhexine expectorants: safety information to be updated
CMDh, Last updated: 27/02/2015 -
List item
Press release: CMDh endorses restricted use of bromocriptine for stopping breast milk production
CMDh, Last updated: 21/08/2014 -
List item
Press release: CMDh endorses suspension of methadone oral solutions containing high molecular weight povidone
CMDh, Last updated: 24/07/2014 -
List item
Press release: CMDh endorses recommendations to restrict the use of diacerein-containing medicines
CMDh, Last updated: 21/03/2014 -
List item
Press release: Acipimox only to be used as additional or alternative treatment to reduce high triglyceride levels
CMDh, Last updated: 20/12/2013 -
List item
Press release: Numeta G13%E to be suspended and new risk-minimisation measures to be introduced for Numeta G16%E
CMDh, Last updated: 20/09/2013 -
List item
Press release: Restrictions in the use of flupirtine-containing medicines - CMDh endorses PRAC recommendation
CMDh, Last updated: 28/06/2013 -
List item
Press release: Restrictions on use of codeine for pain relief in children – CMDh endorses PRAC recommendation
CMDh, Last updated: 28/06/2013